Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.010x

Based on the latest financial reports, Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) has a cash flow conversion efficiency ratio of 0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥127.35 Million ≈ $18.63 Million USD) by net assets (CN¥12.27 Billion ≈ $1.80 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Review financial agility of Beijing Wantai Biological Pharmacy Enter to assess the company's free cash flow relative to its total liabilities.

Beijing Wantai Biological Pharmacy Enterprise Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Beijing Wantai Biological Pharmacy Enterprise Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see Beijing Wantai Biological Pharmacy Enter market capitalisation for the company's overall valuation and market capitalisation.

Beijing Wantai Biological Pharmacy Enterprise Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Beijing Wantai Biological Pharmacy Enterprise Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shenzhen New Industries Biomedical SHE:300832	0.069x
Samsung Securities KO:016360	-0.124x
Coca-Cola FEMSA S.A.B. de C.V MX:KOFUBL	0.074x
Huaan Securities Co Ltd SHG:600909	0.085x
Northam Platinum Holdings Ltd JSE:NPH	0.152x
Casella Waste Systems Inc NASDAQ:CWST	0.040x
Erasca Inc NASDAQ:ERAS	-0.070x
Blue Owl Capital Corporation NYSE:OBDC	-0.004x

Annual Cash Flow Conversion Efficiency for Beijing Wantai Biological Pharmacy Enterprise Co Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Beijing Wantai Biological Pharmacy Enterprise Co Ltd from 2013 to 2025. View today's stock price for Beijing Wantai Biological Pharmacy Enter for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥12.03 Billion ≈ $1.76 Billion	CN¥89.75 Million ≈ $13.13 Million	0.007x	-73.85%
2024-12-31	CN¥12.45 Billion ≈ $1.82 Billion	CN¥355.08 Million ≈ $51.96 Million	0.029x	-77.09%
2023-12-31	CN¥12.88 Billion ≈ $1.89 Billion	CN¥1.60 Billion ≈ $234.72 Million	0.125x	-62.15%
2022-12-31	CN¥12.56 Billion ≈ $1.84 Billion	CN¥4.13 Billion ≈ $604.73 Million	0.329x	-10.78%
2021-12-31	CN¥4.56 Billion ≈ $667.64 Million	CN¥1.68 Billion ≈ $246.12 Million	0.369x	+103.17%
2020-12-31	CN¥2.58 Billion ≈ $377.59 Million	CN¥468.21 Million ≈ $68.51 Million	0.181x	+5.19%
2019-12-31	CN¥1.58 Billion ≈ $231.31 Million	CN¥272.68 Million ≈ $39.90 Million	0.173x	+13.49%
2018-12-31	CN¥1.37 Billion ≈ $200.54 Million	CN¥208.31 Million ≈ $30.48 Million	0.152x	-7.02%
2017-12-31	CN¥898.99 Million ≈ $131.55 Million	CN¥146.97 Million ≈ $21.51 Million	0.163x	+21.25%
2016-12-31	CN¥959.70 Million ≈ $140.43 Million	CN¥129.40 Million ≈ $18.94 Million	0.135x	-35.82%
2015-12-31	CN¥722.69 Million ≈ $105.75 Million	CN¥151.84 Million ≈ $22.22 Million	0.210x	-7.93%
2014-12-31	CN¥580.32 Million ≈ $84.92 Million	CN¥132.43 Million ≈ $19.38 Million	0.228x	-10.88%
2013-12-31	CN¥382.06 Million ≈ $55.91 Million	CN¥97.83 Million ≈ $14.32 Million	0.256x	--

About Beijing Wantai Biological Pharmacy Enterprise Co Ltd

SHG:603392 China Biotechnology

Market Cap

$5.64 Billion

CN¥38.51 Billion CNY

Market Cap Rank

#3321 Global

#456 in China

Share Price

CN¥30.46

Change (1 day)

-0.23%

52-Week Range

CN¥26.27 - CN¥62.34

All Time High

CN¥142.90